Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis

Background. The clinical relevance of Aspergillus fumigatus (Af) in cystic fibrosis (CF) is controversial. The aims of the study were to assess the prevalence of Af disease in our cohort of CF patients and evaluate whether allergic bronchopulmonary aspergillosis (ABPA) and sensitization to Af affect...

Full description

Bibliographic Details
Main Authors: Valentina Fainardi, Chiara Sodini, Michela Deolmi, Andrea Ciuni, Kaltra Skenderaj, Maria Bice Stabile, Cosimo Neglia, Elena Mariotti Zani, Cinzia Spaggiari, Nicola Sverzellati, Susanna Esposito, Giovanna Pisi
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/10/4/739
_version_ 1797444806920634368
author Valentina Fainardi
Chiara Sodini
Michela Deolmi
Andrea Ciuni
Kaltra Skenderaj
Maria Bice Stabile
Cosimo Neglia
Elena Mariotti Zani
Cinzia Spaggiari
Nicola Sverzellati
Susanna Esposito
Giovanna Pisi
author_facet Valentina Fainardi
Chiara Sodini
Michela Deolmi
Andrea Ciuni
Kaltra Skenderaj
Maria Bice Stabile
Cosimo Neglia
Elena Mariotti Zani
Cinzia Spaggiari
Nicola Sverzellati
Susanna Esposito
Giovanna Pisi
author_sort Valentina Fainardi
collection DOAJ
description Background. The clinical relevance of Aspergillus fumigatus (Af) in cystic fibrosis (CF) is controversial. The aims of the study were to assess the prevalence of Af disease in our cohort of CF patients and evaluate whether allergic bronchopulmonary aspergillosis (ABPA) and sensitization to Af affected lung function, body mass index (BMI) and exacerbations. Methods. Clinical data and lung function of CF patients aged 6–18 years followed at the CF Centre of Parma (Italy) were recorded. Patients were classified as: patients with no signs of Af, patients sensitized or colonized by Af, patients with ABPA or patients with Aspergillus bronchitis (Ab). Results. Of 38 CF patients (14.2 years (6.2–18.8) M 23), 8 (21%) showed Af sensitization, 7 (18.4%) showed ABPA, 1 (2.6%) showed Af colonization and 1 (2.6%) showed Ab. Compared to non-ABPA, patients with ABPA had lower BMI (15.9 ± 1.6 vs. 19.7 ± 3.4, <i>p</i> < 0.005), lower lung function (FEV<sub>1</sub> 61.5 ± 25.9% vs. 92.3 ± 19.3%, <i>p</i> < 0.001) and more exacerbations/year (4.43 ± 2.44 vs. 1.74 ± 2.33, <i>p</i> < 0.005). Patients with Af sensitization showed more exacerbations/year than non-Af patients (3.5 ± 3.2 vs. 0.9 ± 1.2, <i>p</i> < 0.005). ABPA and sensitized patients had more abnormalities on chest CT scans. Conclusion. This study showed the relevant clinical impact of ABPA and Af sensitization in terms of exacerbations and lung structural damage.
first_indexed 2024-03-09T13:16:52Z
format Article
id doaj.art-d946b89da14c4cc9846c1a1e34ed63a4
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-09T13:16:52Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-d946b89da14c4cc9846c1a1e34ed63a42023-11-30T21:35:06ZengMDPI AGMicroorganisms2076-26072022-03-0110473910.3390/microorganisms10040739Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic FibrosisValentina Fainardi0Chiara Sodini1Michela Deolmi2Andrea Ciuni3Kaltra Skenderaj4Maria Bice Stabile5Cosimo Neglia6Elena Mariotti Zani7Cinzia Spaggiari8Nicola Sverzellati9Susanna Esposito10Giovanna Pisi11Cystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyScienze Radiologiche, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyScienze Radiologiche, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyCystic Fibrosis Unit, Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, ItalyBackground. The clinical relevance of Aspergillus fumigatus (Af) in cystic fibrosis (CF) is controversial. The aims of the study were to assess the prevalence of Af disease in our cohort of CF patients and evaluate whether allergic bronchopulmonary aspergillosis (ABPA) and sensitization to Af affected lung function, body mass index (BMI) and exacerbations. Methods. Clinical data and lung function of CF patients aged 6–18 years followed at the CF Centre of Parma (Italy) were recorded. Patients were classified as: patients with no signs of Af, patients sensitized or colonized by Af, patients with ABPA or patients with Aspergillus bronchitis (Ab). Results. Of 38 CF patients (14.2 years (6.2–18.8) M 23), 8 (21%) showed Af sensitization, 7 (18.4%) showed ABPA, 1 (2.6%) showed Af colonization and 1 (2.6%) showed Ab. Compared to non-ABPA, patients with ABPA had lower BMI (15.9 ± 1.6 vs. 19.7 ± 3.4, <i>p</i> < 0.005), lower lung function (FEV<sub>1</sub> 61.5 ± 25.9% vs. 92.3 ± 19.3%, <i>p</i> < 0.001) and more exacerbations/year (4.43 ± 2.44 vs. 1.74 ± 2.33, <i>p</i> < 0.005). Patients with Af sensitization showed more exacerbations/year than non-Af patients (3.5 ± 3.2 vs. 0.9 ± 1.2, <i>p</i> < 0.005). ABPA and sensitized patients had more abnormalities on chest CT scans. Conclusion. This study showed the relevant clinical impact of ABPA and Af sensitization in terms of exacerbations and lung structural damage.https://www.mdpi.com/2076-2607/10/4/739cystic fibrosisAspergillusABPAlung functionchest CTfungal infection
spellingShingle Valentina Fainardi
Chiara Sodini
Michela Deolmi
Andrea Ciuni
Kaltra Skenderaj
Maria Bice Stabile
Cosimo Neglia
Elena Mariotti Zani
Cinzia Spaggiari
Nicola Sverzellati
Susanna Esposito
Giovanna Pisi
Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
Microorganisms
cystic fibrosis
Aspergillus
ABPA
lung function
chest CT
fungal infection
title Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
title_full Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
title_fullStr Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
title_full_unstemmed Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
title_short Clinical Impact of <i>Aspergillus fumigatus</i> in Children with Cystic Fibrosis
title_sort clinical impact of i aspergillus fumigatus i in children with cystic fibrosis
topic cystic fibrosis
Aspergillus
ABPA
lung function
chest CT
fungal infection
url https://www.mdpi.com/2076-2607/10/4/739
work_keys_str_mv AT valentinafainardi clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT chiarasodini clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT micheladeolmi clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT andreaciuni clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT kaltraskenderaj clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT mariabicestabile clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT cosimoneglia clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT elenamariottizani clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT cinziaspaggiari clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT nicolasverzellati clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT susannaesposito clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis
AT giovannapisi clinicalimpactofiaspergillusfumigatusiinchildrenwithcysticfibrosis